The chart above plots the price of IVF over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 64 sessions over that window: $1.91 on 4 May 2026 through $0.95 on 31 July 2026. Finazon · prior-day close.
Market cap$1.7M
Avg volume328.7K
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 2, 2026
Reddit mentions per day — left axis
Busiest day in the window
Daily closing price, USD — right axis
The chart plots daily Reddit mentions of IVF over the 30 days to 23 July 2026: 9 in total, busiest on 6 July with 2, and 1 on the last day counted. The line is the daily close over the same window: $1.37 on 6 July, $0.95 on 31 July.
The chart plots daily Reddit mentions of IVF over the 90 days to 23 July 2026: 27 in total, busiest on 12 June with 10, and 1 on the last day counted. The line is the daily close over the same window: $1.90 on 5 May, $0.95 on 31 July.
Finazon · prior-day close
IVF insider trades
SEC Form 4
IVF has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 4 December 2025.
DateInsiderTypeSharesValue
03 Dec 2025Szot Matthew KSell4$0K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
04 Dec 2025Szot Matthew KOther (filer-described)3
26 Aug 2025Shum SteveChief Executive OfficerAward42,000
26 Aug 2025DAVIS TRENT DAward45,000
26 Aug 2025Goren AndreaChief Financial OfficerAward50,000
26 Aug 2025Szot Matthew KAward45,000
26 Aug 2025Ryan BarbaraAward45,000
26 Aug 2025Messina RebeccaAward45,000
IVF reported financials
SEC EDGAR XBRL
IVF reported revenue of $6.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$23.3M.
FigureReportedPeriod
Revenue
$6.8M
31 Dec 2025 fiscal year
Net income
−$23.3M
31 Dec 2025 fiscal year
Diluted EPS
−$214.64
31 Dec 2025 fiscal year
Total assets
$24.7M
31 Mar 2026 at period end
Total equity
$15.0M
31 Mar 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
IVF earnings
SEC EDGAR
DatePeriodEPSRevenue
31 Mar 2026Q1 2026$-3.38$2M
31 Dec 2025FY 2025$-214.64$7M
30 Sep 2025FY 2025$-39.40—
30 Jun 2025FY 2025$-364.23—
31 Mar 2025Q1 2025$-3,473.93$2M
31 Dec 2024FY 2024$-3,782.65$7M
30 Sep 2024Q3 2024$-15.11$1M
30 Jun 2024Q2 2024$-22.39$2M
Reported figures & scheduled dates · SEC EDGAR filings
IVF institutional holders
SEC Form 13F
0 of the 45 institutional funds we track reported a IVF position for the quarter ended 31 Mar 2026; the latest of those filings landed 15 May 2026.